Intrust Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,412
Closed -$399K 393
2021
Q2
$399K Sell
2,412
-154
-6% -$25.7K 0.05% 261
2021
Q1
$394K Sell
2,566
-419
-14% -$56.9K 0.06% 262
2020
Q4
$375K Sell
2,985
-55
-2% -$6.15K 0.06% 254
2020
Q3
$309K Sell
3,040
-7
-0.2% -$714 0.05% 250
2020
Q2
$296K Buy
+3,047
New +$284K 0.06% 263
2020
Q1
Sell
-1,966
Closed -$219K 370
2019
Q4
$219K Buy
+1,966
New +$202K 0.05% 319
2019
Q2
Sell
-2,154
Closed -$237K 380
2019
Q1
$237K Buy
+2,154
New +$225K 0.06% 346
2018
Q4
Sell
-2,216
Closed -$244K 401
2018
Q3
$244K Sell
2,216
-42
-2% -$4.37K 0.06% 336
2018
Q2
$211K Buy
+2,258
New +$194K 0.06% 352
2018
Q1
Sell
-2,237
Closed -$204K 382
2017
Q4
$204K Buy
+2,237
New +$186K 0.06% 362

Other funds holding PRAH

Intrust Bank's PRAH Position: Q3 2021 in Review

Intrust Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,412 shares — an estimated $399K sold.

Intrust Bank first reported a position in PRAH in Q4 2017 and held it in 10 quarters. The position peaked at $399K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Intrust Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Intrust Bank sold 2,412 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $399K.
  • Intrust Bank first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 10 quarters.
  • Intrust Bank's PRA Health Sciences, Inc. position peaked at $399K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Intrust Bank's 13F filing for Q3 2021, filed 4 Nov 2021.